Sophia Genetics (NASDAQ: SOPH) is pioneering the field of data-driven medicine, via its unique technology platform capable of analyzing complex health data (“multimodal data”) and breaking data silos within and across institutions. Its AI-driven SOPHiA DDM™ platform decentralizes mountains of health data and connects seemingly obscure points within that data to inspire breakthroughs for the toughest medical mysteries, enabling healthcare providers across the globe to make data-driven decisions for each patient within the walls of their own institution. The company is headquartered in Rolle (Switzerland).